Recruiting Scleroderma Studies in Ann Arbor
About Scleroderma Clinical Trials in Ann Arbor
Scleroderma is an autoimmune connective tissue disease characterized by hardening and tightening of the skin and connective tissues. Systemic sclerosis can also affect internal organs including lungs, kidneys, and heart. Treatment is directed at specific symptoms and organ involvement.
There are currently 12 scleroderma clinical trials recruiting participants in Ann Arbor, MI. These studies are seeking a combined 1,226 participants. Research is being sponsored by Nkarta, Inc., Novartis Pharmaceuticals, Galderma R&D and 7 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.
Scleroderma Clinical Trials in Ann Arbor — FAQ
Are there scleroderma clinical trials in Ann Arbor?
Yes, there are 12 scleroderma clinical trials currently recruiting in Ann Arbor, MI. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Ann Arbor?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Ann Arbor research site will contact you about next steps.
Are clinical trials in Ann Arbor free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Ann Arbor studies also compensate for your time and travel.
What scleroderma treatments are being tested?
The 12 active trials in Ann Arbor are testing new therapies including novel drugs, biologics, and treatment approaches for scleroderma.
Data updated July 18, 2026 from ClinicalTrials.gov